Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP666180.RAeKs4kmFsNY-UakHopCiQ2zn9BBnhWJ4uSRMKW5nnY3s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP666180.RAeKs4kmFsNY-UakHopCiQ2zn9BBnhWJ4uSRMKW5nnY3s130_assertion type Assertion NP666180.RAeKs4kmFsNY-UakHopCiQ2zn9BBnhWJ4uSRMKW5nnY3s130_head.
- NP666180.RAeKs4kmFsNY-UakHopCiQ2zn9BBnhWJ4uSRMKW5nnY3s130_assertion description "[Our results suggest that DNMT1, DNMT3b, and MBD2 may play important roles in modulating NSCLC patient survival and thus be useful for identifying NSCLC patients who would benefit most from aggressive therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP666180.RAeKs4kmFsNY-UakHopCiQ2zn9BBnhWJ4uSRMKW5nnY3s130_provenance.
- NP666180.RAeKs4kmFsNY-UakHopCiQ2zn9BBnhWJ4uSRMKW5nnY3s130_assertion evidence source_evidence_literature NP666180.RAeKs4kmFsNY-UakHopCiQ2zn9BBnhWJ4uSRMKW5nnY3s130_provenance.
- NP666180.RAeKs4kmFsNY-UakHopCiQ2zn9BBnhWJ4uSRMKW5nnY3s130_assertion SIO_000772 18414412 NP666180.RAeKs4kmFsNY-UakHopCiQ2zn9BBnhWJ4uSRMKW5nnY3s130_provenance.
- NP666180.RAeKs4kmFsNY-UakHopCiQ2zn9BBnhWJ4uSRMKW5nnY3s130_assertion wasDerivedFrom befree-2016 NP666180.RAeKs4kmFsNY-UakHopCiQ2zn9BBnhWJ4uSRMKW5nnY3s130_provenance.
- NP666180.RAeKs4kmFsNY-UakHopCiQ2zn9BBnhWJ4uSRMKW5nnY3s130_assertion wasGeneratedBy ECO_0000203 NP666180.RAeKs4kmFsNY-UakHopCiQ2zn9BBnhWJ4uSRMKW5nnY3s130_provenance.